Hepatitis C virus replication-specific inhibition of MicroRNA activity with self-cleavable allosteric ribozyme

Nucleic Acid Therapeutics

Volumn 22, Issue 1, 2012, Pages 17-29

  Lee, Chang Ho ^a   Kim, Ji Hyun ^a   Kim, Hee Won ^a   Myung, Heejoon ^b   Lee, Seong Wook ^a  

^a Dankook University   (South Korea)

^b Hankuk University of Foreign Studies   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; COMPLEMENTARY RNA; MICRORNA; NONSTRUCTURAL PROTEIN 5B; RIBOZYME;

3' UNTRANSLATED REGION; ALLOSTERISM; ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; GENE CONSTRUCT; GENE SEQUENCE; GENE SILENCING; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REPLICON; REPORTER GENE; VIREMIA; VIRUS REPLICATION;

ALLOSTERIC REGULATION; BASE SEQUENCE; DNA PRIMERS; HEPACIVIRUS; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, CATALYTIC; VIRUS REPLICATION;

EID: 84863171531     PISSN: 21593337     EISSN: None     Source Type: Journal    
DOI: 10.1089/nat.2011.0326     Document Type: Article

References (37)

1. BARTENSCHLAGER, R., FRESE, M., and PIETSCHMANN, T. (2004). Novel insights into hepatitis C virus replication and persistence. Adv. Virus Res. 63, 71-180. (Pubitemid 39752303)
2. CHANG, J., NICOLAS, E., MARKS, D., SANDER, C., LERRO, A., BUENDIA, M.A., XU, C., MASON, W.S., MOLOSHOK, T., BORT, R., ZARET, K.S., and TAYLOR, J.M. (2004). miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter. RNA Biol. 1, 106-113.
3. CHEKULAEVA, M., and FILIPOWICZ, W. (2009). Mechanisms of miRNA-mediated post-translational regulation in animal cells. Curr. Opin. Cell Biol. 21, 452-460.
4. CICCAGLIONE, A.R., MARCANTONIO, C., TRITARELLI, E., TATASEO, P., FERRARIS, A., BRUNI, R., DALLAPICCOLA, B., GEROSOLIMO, G., COSTANTINO, A., and RAPICETTA, M. (2008). Microarray analysis identifies a common set of cellular genes modulated by different HCV replicon clones. BMC Genom. 9, 309-321.
5. COULOUARN, C., FACTOR, V.M., ANDERSEN, J.B., DURKIN, M.E., and THORGEIRSSON, S.S. (2009). Loss of mir-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene 28, 3526-3536.
6. ELMÉ N, J., LINDOW, M., SHUTZ, S., LAWRENCE, M., PETRI, A., OBAD, S., LINDHOLM, M., HEDTJÄ RN, M., HANSEN, H.F., BERGER, U., GULLANS, S., KEARNEY, P., SARNOW, P., STRAARUP, E.M., and KAUPPINEN, S. (2008a). LNAmediated microRNA silencing in non-human primates. Nature 452, 896-899. (Pubitemid 351550859)
7. ELMÉ N, J., LINDOW, M., SILAHTAROGLU, A., BAK, M., CHRISTENSEN, M., LIND-THOMSEN, A., HEDTJÄ RN, M., HANSEN, J.B., HANSEN, H.F., STRAARUP, E.M., McCULLAGH, K., KEARNEY, P., and KAUPPINEN, S. (2008b). Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res. 36, 1153-1162. (Pubitemid 351330933)
8. ESAU, C., DAVIS, S., MURRAY, S.F., YU, X.X., PANDEY, S.K., PEAR, M., WATTS, L., BOOTEN, S.L., GRAHAM, M., McKAY, R., SUBRAMANIAM, A., PROPP, S., LOLLO, B.A., FREIER, S., BENNETT, C.F., BHANOT, S., and MONIA, B.P. (2006). miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 3, 87-98.
9. GRAMANTIERI, L., FERRACIN, M., FORNARI, F., VERONESE, A., SABBIONI, S., LIU, C.G., CALIN, G.A., GIOVANNINI, C., FERRAZZI, E., GRAZI, G.L., CROCE, C.M., BOLONDI, L., and NEGRINI, M. (2007). Cyclin G1 is a target of miR-122a, a microRNA frequently downregulated in human hepatocellular carcinoma. Cancer Res. 67, 6092-6099. (Pubitemid 47037488)
10. HENKE, J.I., GOERGEN, D., ZHENG, J., SONG, Y., SCH}UTTLER, C.G., FEHR, C., JÜ NEMANN, C., and NIEPMANN, M. (2008). microRNA-122 stimulates translation of hepatitis C virus RNA. EMBO J. 27, 3300-3310.
11. HUGLE, T., and CERNY, A. (2003). Current therapy and new molecular approaches to antiviral treatment and prevention of hepatitis C. Rev. Med. Virol. 13, 361-371. (Pubitemid 37413258)
12. HWANG, B., CHO, J.S., YEO, H.J., KIM, J.H., CHUNG, K.M., HAN, K., JANG, S.K., and LEE, S.W. (2004). Isolation of specific and high-affinity RNA aptamers against NS3 helicase domain of hepatitis C virus. RNA 10, 1277-1290. (Pubitemid 38989013)
13. JANGRA, R.K., YI, M., and LEMON, S.M. (2010). Regulation of hepatitis C virus translation and infectious virus production by the microRNA miR-122. J. Virol. 84, 6615-6625.
14. JOPLING, C.L., YI, M., LANCASTER, A.M., LEMON, S.M., and SARNOW, P. (2005). Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 309, 1577-1581. (Pubitemid 41266486)
15. KERTSBURG, A., and SOUKUP, G.A. (2002). A versatile communication module for controlling RNA folding and catalysis. Nucleic Acids Res. 30, 4599-4606. (Pubitemid 35331740)
16. KHALIQ, S., KHALIQ, S.A., ZAHUR, M., IJAZ, B., JAHAN, S., ANSAR, M., RIAZUDDIN, S., and HASSAN, S. (2010). RNAi as a new therapeutic strategy against HCV. Biotechnol. Adv. 28, 27-34.
17. KIM, S.J., KIM, J.H., SUN, J.M., KIM, M.G., and OH, J.W. (2009). Suppression of hepatitis C virus replication by protein kinase C-related kinase 2 inhibitors that block phosphorylation of viral RNA polymerase. J. Viral Hepat. 16, 697-704.
18. KLEBL, B.M., KURTENBACH, A., SALASSIDIS, K., DAUB, H., and HERGET, T. (2005). Host cell targets in HCV therapy: novel strategy or proven practice? Antivir. Chem. Chemother. 16, 69-90. (Pubitemid 41529728)
19. KRIEGER, N., LOHMANN, V., and BARTENSCHLAGER, R. (2001). Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations. J. Virol. 75, 4614-4624. (Pubitemid 32381503)
20. KRÜ TZFELDT, J., RAJEWSKY, N., BRAICH, R., RAJEEV, K.G., TUSCHL, T., MANOHARAN, M., and STOFFEL, M. (2005). Silencing of microRNAs in vivo with 'anagomir'. Nature 438, 685-689.
21. LANFORD, R.E., HILDEBRANDT-ERIKSEN, E.S., PETRI, A., PERSSON, R., LINDOW, M., MUNK, M.E., KAUPPINEN, S., and ØRUM, H. (2010). Therapeutic silencing of micro-RNA-122 in primates with chronic hepatitis C virus infection. Science 327, 198-201.
22. LAUER, G.M., and WALKER, B.D. (2001). Hepatitis C virus infection. New Engl. J. Med. 345, 41-52. (Pubitemid 32634271)
23. LOHMANN, V., KORNER, F., KOCH, J.O., HERIAN, U., THEILMANN, L., and BARTENSCHLAGER, R. (1999). Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285, 110-113. (Pubitemid 29307577)
24. LONG, D.M., and UHLENBECK, O.C. (1994). Kinetic characterization of intramolecular and intermolecular hammerhead RNAs with stem II deletions. Proc. Natl. Acad. Sci. U. S. A. 91, 6977-6981.
25. MORADPOUR., D., BRASS, V., GOSERT, R., WOLK, B., and BLUM, H. (2002). Hepatitis C: molecular virology and antiviral targets. Trends Mol. Med. 8, 476-482.
26. MURAKAMI, Y., ALY, H.H., TAJIMA, A., INOUE, I., and SHIMOTOHNO, K. (2009). Regulation of the hepatitis C virus genome replication by miR-199a. J. Hepatol. 50, 453-460.
27. OKAMOTO, T., NISHIMURA, Y., ICHIMURA, T., SUZUKI, K., MIYAMURA, T., SUZUKI, T., MORIISHI, K., and MATSUURA, Y. (2006). Hepatitis C virus RNA replication is regulated by FKBP8 and Hsp90. EMBO J. 25, 5015-5025. (Pubitemid 44607045)
28. PAUL, C.P., GOOD, P.D., LI, S.X., KLEIHAUER, A., ROSSI, J.J., and ENGELKE, D.R. (2003). Localized expression of small RNA inhibitors in human cells. Mol. Ther. 7, 237-247. (Pubitemid 36395359)
29. ROTH, A., and BREAKER, R.R. (2004). Selection in vitro of allosteric ribozymes. Methods Mol. Biol. 252, 145-164.
30. RYU, K.J., KIM, J.H., and LEE, S.W. (2003). Ribozyme-mediated selective induction of new gene activity in hepatitis C virus internal ribosome entry site-expressing cells by targeted transsplicing. Mol. Ther. 7, 386-395.
31. SCHERR, M., VENTURINI, L., BATTMER, K., SCHALLERSCHOENITZ, M., SCHAEFER, D., DALLMANN, I., GANSER, A., and EDER, M. (2007). Lentivirus-mediated antagomir expression for specific inhibition of miRNA function. Nucleic Acids Res. 35, e149.
32. SHIN, K.S., LIM, J.H., KIM, J.H., MYUNG, H., and LEE, S.W. (2006). Inhibition of the replication of hepatitis C virus replicon with nuclease-resistant RNA aptamers. J. Microbiol. Biotechnol. 16, 1634-1639. (Pubitemid 44755955)
33. SOUKUP, G.A., and BREAKER, R.R. (1999). Engineering precision RNA molecular switches. Proc. Natl. Acad. Sci. U. S. A. 96, 3584-3589. (Pubitemid 29168953)
34. TSAI, W.C., HSU, P.W., LAI, T.C., CHAU, G.Y., LIN, C.W., CHEN, C.M., LIN, C.D., LIAO, Y.L., WANG, J.L., CHAU, Y.P., HSU, M.T., HSIAO, M., HUANG, H.D., and TSOU, A.P. (2009). MicroRNA-122, a tumor suppressor microRNA that regulates metastasis of hepatocellular carcinoma. Hepatology 49, 1571-1582.
35. TUSCHL, T., and ECKSTEIN, F. (1993). Hammerhead ribozymes: importance of stem-loop II for activity. Proc. Natl. Acad. Sci. U. S. A. 90, 6991-6994. (Pubitemid 23222374)
36. WATASHI, K., ISHII, N., HIJIKATA, M., INOUE, D., MURATA, T., MIYANARI, Y., and SHIMOTOHNO, K. (2005). Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase. Mol. Cell 19, 111-122. (Pubitemid 40884662)
37. YE, J., WANG, C., SUMPTER, R. JR, BROWN, M.S., GOLDSTEIN, J.L., and GALE, M, JR. (2003). Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation. Proc. Natl. Acad. Sci. U. S. A. 100, 15865-15870. (Pubitemid 38021081)